References: Stumhofer JS, Tait ED, Quinn WJ 3rd, Hosken N, Spudy B, Goenka R, Fielding CA, O’Hara AC, Chen Y, Jones ML, Saris CJ, Rose-John S, Cua DJ, Jones SA, Elloso MM, Grotzinger J, Cancro MP, Levin SD, Hunter CA. A Role for IL-27p28 as an antagonist of gp130-mediated signaling. Nat Immunol. 2010 Dec;11(12):1119-26.
Stumhofer JS and Hunter CA. Advances in understanding the anti-inflammatory properties of IL-27. Immunol Lett. 2008 May 15; 117(2): 123-30.
Yoshimura A, Yoshida H, Miyazaki Y, Kinjyo I, Ishibashi T, Yoshimura T, Takeda A, Hamano S. Two sided roles of IL- 27: induction of Th1 differentiation on Naïve CD4+ T cells versus suppression of proinflammatory cytokine production including IL-23-induced IL-17 on activated CD4+ T cells partially through STAT3-dependent mechanism. J Immunol. 2006; 177: 5377-85.